Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neuropathic Pain Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuropathic Pain Drugsmarket, defines the market attractiveness level of Neuropathic Pain Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuropathic Pain Drugs industry, describes the types of Neuropathic Pain Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuropathic Pain Drugs market and the development prospects and opportunities of Neuropathic Pain Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuropathic Pain Drugs market in Chapter 13.
By Player:
Eli Lilly
GlaxoSmithKline
Pfizer
Sanofi
Bristol-Myers Squibb
Johnson & Johnson
Biogen
Depomed
Baxter Healthcare
By Type:
Tricyclic Anti-Depressants Anticonvulsants
Serotonin-Norepinephrine Reuptake Inhibitor
Capsaicin Cream
Local Anaesthesia
Opioids
Steroids
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuropathic Pain Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuropathic Pain Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuropathic Pain Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuropathic Pain Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuropathic Pain Drugs Market Analysis and Outlook to 2022
-
7.1 Global Neuropathic Pain Drugs Consumption (2017-2022)
-
7.2 United States Neuropathic Pain Drugs Consumption (2017-2022)
-
7.3 Europe Neuropathic Pain Drugs Consumption (2017-2022)
-
7.4 China Neuropathic Pain Drugs Consumption (2017-2022)
-
7.5 Japan Neuropathic Pain Drugs Consumption (2017-2022)
-
7.6 India Neuropathic Pain Drugs Consumption (2017-2022)
-
7.7 South Korea Neuropathic Pain Drugs Consumption (2017-2022)
8 Region and Country-wise Neuropathic Pain Drugs Market Analysis and Outlook to 2028
-
8.1 Global Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.2 United States Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.4 China Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.6 India Neuropathic Pain Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Neuropathic Pain Drugs Consumption Forecast (2022-2028)
9 Global Neuropathic Pain Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Neuropathic Pain Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tricyclic Anti-Depressants Anticonvulsants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Serotonin-Norepinephrine Reuptake Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Capsaicin Cream Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Local Anaesthesia Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Opioids Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Steroids Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuropathic Pain Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Neuropathic Pain Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Neuropathic Pain Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tricyclic Anti-Depressants Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Serotonin-Norepinephrine Reuptake Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Capsaicin Cream Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Local Anaesthesia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Opioids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuropathic Pain Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuropathic Pain Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuropathic Pain Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuropathic Pain Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuropathic Pain Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuropathic Pain Drugs Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Neuropathic Pain Drugs Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Neuropathic Pain Drugs Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Neuropathic Pain Drugs Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Neuropathic Pain Drugs Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Neuropathic Pain Drugs Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Neuropathic Pain Drugs Product and Service
-
14.7 Biogen
-
14.7.1 Biogen Company Details
-
14.7.2 Biogen Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biogen Neuropathic Pain Drugs Product and Service
-
14.8 Depomed
-
14.8.1 Depomed Company Details
-
14.8.2 Depomed Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Depomed Neuropathic Pain Drugs Product and Service
-
14.9 Baxter Healthcare
-
14.9.1 Baxter Healthcare Company Details
-
14.9.2 Baxter Healthcare Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Baxter Healthcare Neuropathic Pain Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuropathic Pain Drugs
-
Figure Neuropathic Pain Drugs Picture
-
Table Global Neuropathic Pain Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropathic Pain Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropathic Pain Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuropathic Pain Drugs Consumption by Country (2017-2022)
-
Figure United States Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuropathic Pain Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Neuropathic Pain Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuropathic Pain Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tricyclic Anti-Depressants Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global Serotonin-Norepinephrine Reuptake Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Capsaicin Cream Consumption and Growth Rate (2017-2022)
-
Figure Global Local Anaesthesia Consumption and Growth Rate (2017-2022)
-
Figure Global Opioids Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Tricyclic Anti-Depressants Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Serotonin-Norepinephrine Reuptake Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsaicin Cream Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Local Anaesthesia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuropathic Pain Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuropathic Pain Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Neuropathic Pain Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neuropathic Pain Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neuropathic Pain Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neuropathic Pain Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Neuropathic Pain Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Neuropathic Pain Drugs Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Neuropathic Pain Drugs Product and Service
-
Table Depomed (Foundation Year, Company Profile and etc.)
-
Table Depomed Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Neuropathic Pain Drugs Product and Service
-
Table Baxter Healthcare (Foundation Year, Company Profile and etc.)
-
Table Baxter Healthcare Neuropathic Pain Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Healthcare Neuropathic Pain Drugs Product and Service
-
